
Anixa Biosciences ANIX
$ 3.11
-2.51%
Annual report 2025
added 01-12-2026
Anixa Biosciences EV/EBITDA Ratio 2011-2026 | ANIX
Annual EV/EBITDA Ratio Anixa Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.25 | -5.26 | -6.54 | -4.93 | -4.72 | -12.5 | -36.6 | -7.89 | -6.32 | -9.6 | -4.59 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.25 | -36.6 | -9.2 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 22.32 | -3.71 % | $ 99.4 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.45 | -3.67 % | $ 1.84 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 30.5 | -4.72 % | $ 328 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 40.78 | 1.92 % | $ 1.13 B | ||
|
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | ||
|
DexCom
DXCM
|
39.5 | $ 70.44 | 1.29 % | $ 27.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Guardant Health
GH
|
-28.8 | $ 113.62 | 1.32 % | $ 13.9 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Illumina
ILMN
|
70.5 | $ 147.36 | 4.03 % | $ 23.4 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 20.08 | 0.35 % | $ 1.08 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 234.95 | -0.44 % | $ 172 B | ||
|
Celcuity
CELC
|
-2.38 | $ 105.63 | -1.25 % | $ 4.17 B | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 12.48 | 0.28 % | $ 354 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 27.65 | -1.53 % | $ 836 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 102.21 | -0.22 % | $ 18.9 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 66.02 | 2.75 % | $ 4.57 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 602.32 | -1.41 % | $ 18.6 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 234.18 | -1.47 % | $ 42.5 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.28 | 0.27 % | $ 2.01 B | ||
|
National Research Corporation
NRC
|
21 | $ 22.06 | -0.72 % | $ 541 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 219.04 | -0.3 % | $ 11.3 B | ||
|
OPKO Health
OPK
|
25.9 | $ 1.3 | 1.56 % | $ 902 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 2.36 | 6.79 % | $ 599 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 188.87 | -0.33 % | $ 21 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 8.85 | 12.25 % | $ 1.15 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 409.56 | -3.5 % | $ 29.9 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 272.02 | 0.42 % | $ 22.8 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 176.57 | -3.31 % | $ 14.6 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 688.67 | -3.73 % | $ 56.8 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 5.65 | -4.56 % | $ 512 M | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.67 | -2.3 % | $ 2.51 M | ||
|
Agilent Technologies
A
|
27.4 | $ 135.52 | -2.95 % | $ 41.2 B |